bronchiol
commonest
lower
respiratori
tract
ill
young
children
lead
caus
hospit
age
group
unit
state
result
signific
morbid
mortal
children
less
bronchiol
primarili
viral
ill
respiratori
syncyti
viru
rsv
follow
rhinoviru
rv
common
viral
clinic
spectrum
diseas
vari
mild
ill
requir
hospit
sever
respiratori
failur
necessit
ventilatori
support
intens
care
unit
first
year
life
approxim
children
rsv
seek
medic
major
children
treat
outpati
primari
care
physician
offic
emerg
young
age
comorbid
prematur
congenit
heart
diseas
neuromuscular
diseas
immunodefici
import
risk
factor
determin
sever
diseas
still
difficult
young
infant
method
often
differ
among
bronchiol
clinic
diagnosi
current
standard
method
exist
aid
physician
determin
disposit
patient
clinician
commonli
reli
parent
histori
clinic
find
presenc
absenc
hypoxemia
molecular
diagnost
improv
understand
viral
etiolog
bronchiol
common
occurr
viral
remain
clinic
need
predict
biomark
aid
clinician
manag
disposit
patient
bronchiol
recent
observ
nasal
wash
lactat
dehydrogenas
nwldh
good
predictor
bronchiol
nwldh
invers
correl
diseas
sever
infant
young
children
present
emerg
depart
also
significantli
correl
nwcaspas
activ
marker
apoptosi
shown
correl
serum
observ
valid
multicent
studi
conduct
mansbach
colleagu
also
observ
invers
relationship
nwldh
level
bronchiol
sever
young
children
present
emerg
bronchiol
studi
conduct
emerg
depart
bennett
colleagu
observ
earli
robust
proinflammatori
immun
respons
upper
respiratori
tract
invers
correl
durat
supplementaloxygen
therapi
contribut
sever
synthes
find
studi
hypothes
major
sourc
lactat
dehydrogenas
nasal
wash
children
bronchiol
like
deriv
epitheli
cell
andor
neutrophil
undergo
apoptosi
part
innat
immun
respons
control
viral
infect
rather
cellular
necrosi
epitheli
cell
inflammatori
cell
prospect
singlesit
cohort
studi
bronchiol
extend
origin
observ
includ
wider
spectrum
diseas
sever
children
present
emerg
center
discharg
home
admit
either
gener
ward
intens
care
unit
postul
nwldh
nwcaspas
ratio
nwldh
nwcaspas
predict
biomark
bronchiol
sever
measur
disposit
prospect
crosssect
singlesit
studi
evalu
healthi
children
less
month
age
present
emerg
depart
ed
pediatr
intens
care
unit
icu
clinic
bronchiol
subject
recruit
two
separ
simultan
occur
investig
primari
author
rm
ms
children
enrol
texa
children
hospit
octob
coincid
bronchiol
season
houston
tx
infant
clinic
bronchiol
wheez
andor
rale
histori
preced
upper
airway
ill
month
age
without
signific
comorbid
includ
patient
exclud
greater
month
age
signific
comorbid
medic
condit
exampl
chronic
lung
diseas
cyanot
congenit
heart
diseas
neuromuscular
diseas
immunodefici
state
preterm
week
respiratori
distress
unrel
viral
uri
qualifi
children
enrol
time
came
medic
attent
sampl
ed
icu
within
hour
admiss
obtain
inform
consent
parent
legal
guardian
enrol
physic
exam
perform
demograph
medic
histori
record
nasopharyng
secret
aspir
npa
obtain
viral
diagnost
biomark
interest
enrol
data
collect
sampl
collect
studi
done
primari
investig
rm
ms
involv
medic
care
disposit
subject
child
disposit
outcom
determin
primari
care
team
note
review
medic
record
institut
review
board
baylor
colleg
medicin
approv
studi
singl
npa
sampl
collect
previous
describ
enrol
either
emerg
depart
within
hour
admiss
npa
use
surrog
lower
respiratori
tract
sever
studi
confirm
viru
titer
obtain
nasal
wash
correl
diseas
activ
lower
briefli
npa
collect
instil
cc
normal
salin
extern
nare
aspir
materi
syring
contain
addit
cc
normal
salin
via
flexibl
cathet
sampl
stabil
viral
transport
media
iscov
media
glycerol
dilut
refriger
degre
transport
respiratori
viru
diagnost
laboratori
clia
id
baylor
colleg
medicin
laboratori
specimen
divid
six
aliquot
cc
snapfrozen
alcoholdri
ice
bath
store
npa
gener
process
within
hour
collect
mucu
presenc
npa
specimen
evalu
weekli
enrol
test
presenc
secretori
iga
siga
major
immunoglobulin
mucos
defens
captur
elisa
method
use
commerci
avail
reagent
five
npa
sampl
enrol
children
demonstr
inadequ
siga
level
subject
resampl
virus
npa
identifi
two
method
isol
cultur
four
cell
line
rhesu
monkey
kidney
realtim
pcr
rtpcr
rtpcr
specif
primer
fluoresc
probe
use
identifi
follow
common
virus
rsv
b
rhinoviru
rv
parainfluenza
virus
human
metapneumoviru
hmpv
adenoviru
ad
influenza
virus
b
novel
enteroviru
coronavirus
e
amplif
gene
rnasep
ribonucleas
enzym
serv
posit
intern
control
assess
qualiti
sampl
npa
sampl
cycl
threshold
valu
rnasep
less
consid
optim
qualiti
specimen
consid
reason
qualiti
poor
qualiti
two
npa
sampl
poor
qualiti
rtpcr
remain
either
optim
n
reason
n
qualiti
specimen
ldh
activ
marker
cellular
injuri
ldh
activ
npa
sampl
measur
use
commerci
avail
kit
cytotox
detect
kit
roch
appli
scienc
indianapoli
usa
per
manufactur
instruct
previous
calcul
absolut
valu
standard
curv
use
lldh
roch
appli
scienc
serial
dilut
construct
demonstr
ampl
linear
dynam
rang
r
dilut
test
uml
caspas
activ
marker
apoptosi
caspas
activ
measur
npa
sampl
use
kit
promega
madison
wi
usa
assay
gener
luminesc
activ
proport
caspas
activ
luminesc
measur
fluostar
optima
micropl
reader
bmg
labtech
cari
nc
usa
express
rel
luminesc
unit
calcul
rel
unit
ul
caspas
activ
standard
curv
use
recombin
human
protein
r
system
minneapoli
mn
usa
use
demonstr
ampl
linear
dynam
rang
activ
dilut
test
ul
valu
express
rel
unit
assum
one
unit
caspas
activ
equal
ng
protein
import
note
caspas
activ
vari
lot
lot
outcom
use
primari
analysi
disposit
time
initi
evalu
children
either
discharg
home
observ
home
admit
acut
care
unit
acu
admit
pediatr
neonat
intens
care
unit
icu
demograph
clinic
virolog
biomark
analyz
respect
outcom
age
particip
categor
four
group
month
durat
ill
prior
present
classifi
three
group
day
viral
result
categor
rsv
rv
rsv
rv
coinfect
virus
viru
infect
pattern
singl
viral
infect
co
viral
infect
viru
identifi
descript
statist
continu
variabl
repres
mean
median
standard
deviat
categor
variabl
repres
frequenc
percentag
demograph
characterist
among
group
compar
use
chi
squar
test
fisher
exact
test
analysi
laboratori
data
continu
variabl
nwldh
nwcaspas
nwldhnwcaspas
ratio
compar
demograph
data
includ
disposit
perform
use
analysi
varianc
anova
student
test
test
appropri
given
rang
valu
valu
nwldh
nwcaspas
activ
use
statist
analysi
correl
calcul
use
pearson
spearman
coeffici
identif
independ
factor
may
influenc
disposit
multivari
logist
regress
analys
polytom
respons
perform
calcul
odd
ratio
correspond
confid
interv
identifi
independ
factor
influenc
nwldh
nwcaspas
nwldhnwcaspas
ratio
multipl
linear
regress
model
develop
twoway
interact
effect
control
age
gender
race
durat
ill
exposur
cigarett
smoke
disposit
patient
viru
infect
pattern
relev
biomark
statist
analys
perform
use
sa
softwar
packag
version
sa
institut
inc
cari
nc
usa
respiratori
viral
season
enrol
children
year
age
bronchiol
children
enrol
emerg
depart
children
enrol
within
hour
admiss
pediatr
icu
averag
age
mean
sd
children
month
children
hispan
follow
africanamerican
white
enrol
children
male
children
breastf
half
present
day
ill
children
attend
daycar
children
live
home
smoker
diagnosi
asthma
found
children
demograph
data
particip
stratifi
disposit
home
acu
icu
present
tabl
differ
among
group
term
age
gender
race
asthma
diagnos
group
also
similar
term
exposur
daycar
tobacco
smoke
breastfeed
demograph
variabl
differ
significantli
durat
ill
prior
present
children
present
day
ill
significantli
likeli
admit
acu
icu
p
nasal
wash
serv
surrog
marker
lower
respiratori
tract
viral
pathogen
detect
children
consist
previou
patient
singl
infect
found
coinfect
one
viru
commonli
detect
virus
rsv
n
rv
n
common
respiratori
virus
identifi
includ
human
metapneumoviru
hmpv
n
influenza
n
parainfluenza
n
cytomegoloviru
cmv
n
adenoviru
n
coronaviru
n
enteroviru
n
shown
tabl
neither
viru
infect
type
viru
infect
pattern
impact
disposit
also
differ
disposit
infant
infect
rsva
versu
rsvb
data
shown
nwldh
nwcaspas
nwldhnwcaspas
ratio
normal
transform
analyz
term
disposit
nwldh
vari
significantli
among
three
disposit
group
shown
figur
children
admit
icu
significantli
higher
nwldh
mul
mean
sd
children
sent
home
mean
sd
admit
acu
mean
sd
nwldh
also
vari
significantli
viru
type
illustr
figur
children
infect
rsv
alon
highest
nwldh
concentr
mul
mean
sd
compar
coinfect
rsv
rv
rv
anoth
viru
type
howev
univari
analysi
indic
singli
infect
patient
significantli
higher
nwldh
compar
coinfect
patient
viru
identifi
although
trend
toward
higher
nwldh
singli
infect
patient
data
shown
demonstr
strong
correl
r
p
nwldh
nwcaspas
activ
illustr
figur
interestingli
nwcaspas
activ
differ
among
disposit
group
signific
p
howev
nwcaspas
activ
vari
significantli
viru
type
rsv
rv
rsv
rv
other
p
seen
figur
patient
infect
rsv
highest
caspas
level
nasal
wash
mean
sd
compar
coinfect
rsv
rv
rv
type
virus
addit
nwldhnwcaspas
ratio
differ
disposit
group
achiev
statist
signific
p
howev
children
divid
two
disposit
group
hospit
nwldh
nwcaspas
ratio
hospit
group
significantli
higher
mean
sd
median
children
hospit
median
p
multivari
logist
regress
analys
conduct
use
disposit
patient
home
acu
icu
primari
outcom
identifi
demograph
biomark
variabl
contribut
disposit
analysi
demonstr
children
younger
month
like
admit
acu
ci
versu
sent
home
compar
children
older
month
ii
compar
children
present
day
ill
later
children
present
day
symptom
significantli
like
admit
either
acu
ci
icu
ci
iii
oneunit
increas
nwldh
mul
associ
increas
likelihood
admiss
either
acu
ci
icu
ci
iv
contrast
oneunit
increas
nwcaspas
activ
ul
associ
decreas
likelihood
admit
acu
ci
three
multipl
linear
regress
model
construct
evalu
demograph
clinic
virolog
variabl
impact
biomark
interest
tabl
independ
variabl
interact
term
provid
best
rsquar
valu
use
construct
model
rsquar
valu
indic
model
explain
variat
nwldh
nwcaspas
nwldhcaspas
ratio
respect
coeffici
standard
error
shown
independ
variabl
asterisk
indic
signific
variabl
result
indic
male
children
higher
nwldh
compar
femal
hispan
children
lower
nwldh
nwldhcaspas
ratio
compar
nonhispan
children
higher
nwldh
nwldhnwcaspas
ratio
significantli
associ
acu
admiss
nwcaspas
activ
invers
associ
acu
admiss
nwldh
significantli
lower
nwcaspas
significantli
higher
children
identifi
pathogen
nwldh
highli
associ
nwcaspas
account
interact
term
sever
independ
variabl
modifi
effect
independ
factor
may
import
consider
determin
sever
bronchiol
exampl
children
month
old
hospit
acu
actual
lower
nwldh
nwldhnwcaspas
ratio
children
age
month
sent
home
also
children
expos
secondhand
cigarett
smoke
hospit
acu
higher
nwldh
nwldhnwcaspas
ratio
sent
home
live
nonsmok
hispan
patient
infect
singl
viru
coinfect
multipl
virus
significantli
higher
nwldh
lower
nwcaspas
higher
nwldhnwcaspas
ratio
viru
identifi
compar
race
p
studi
identifi
ad
complex
use
promis
biomark
nwldh
children
bronchiol
intracellular
enzym
releas
upon
cell
injuri
nwldh
marker
necrosi
apoptosi
similar
prior
rsv
infect
associ
higher
nwldh
nwldh
significantli
correl
nwcaspas
unlik
prior
studi
children
valu
upper
quartil
decreas
risk
studi
increas
concentr
nwldh
associ
increas
likelihood
hospit
either
acu
icu
children
admit
icu
significantli
higher
nwldh
children
sent
home
admit
acu
differ
predict
outcom
readili
explain
howev
higher
proport
cohort
requir
icu
care
versu
none
children
major
comorbid
compar
laham
et
al
possibl
current
cohort
children
sever
bronchiol
result
greater
cellular
injuri
airway
epithelium
thu
understand
mechan
apoptosi
versu
necrosi
underli
releas
ldh
might
improv
predict
outcom
implic
nwldh
cell
undergo
dysregul
inflammatori
necrot
process
result
sever
diseas
nwldh
origin
control
apoptot
antivir
process
result
less
sever
diseas
address
issu
evalu
caspas
caspas
play
vital
role
biomark
apoptosi
caspas
effector
caspas
break
intracellular
protein
trigger
apoptot
pathway
reason
children
greater
nwcaspas
activ
like
control
antivir
proinflammatori
respons
less
sever
ill
previou
studi
shown
role
granulocyt
respiratori
epitheli
cell
apoptosi
antivir
investig
shown
incub
rsv
granulocyt
inhibit
apoptosi
vitro
studi
rsv
posit
infant
shown
increas
granulocyt
apoptosi
studi
highlight
epitheli
cell
apoptosi
rare
earli
predomin
later
phase
result
suggest
appropri
regul
apoptot
respons
complex
process
influenc
sever
diseas
multivari
logist
regress
analys
observ
oneunit
increas
nwcaspas
activ
ul
associ
decreas
likelihood
admit
acu
ci
support
nwldhnwcaspas
ratio
children
go
home
er
significantli
lower
nwldhnwcaspas
ratio
compar
hospit
children
mean
sd
versu
p
possibl
reflect
balanc
innat
immun
respons
viral
pathogen
relationship
nwldh
nwcaspas
crucial
find
suggest
nwldh
nwcaspas
alon
may
suffici
marker
togeth
help
predict
sever
bronchiol
multipl
linear
regress
analys
demonstr
interact
effect
demograph
variabl
may
signific
chang
predict
sever
bronchiol
univari
model
show
higher
nwldh
nwldhnwcaspas
ratio
strongli
link
sever
ill
hospit
icu
acu
interestingli
multipl
linear
model
use
analys
age
subject
differ
level
disposit
also
greatli
impact
chang
biomark
children
month
age
hospit
acu
actual
lower
nwldh
sent
home
whose
age
greater
month
trend
result
previou
thu
demograph
interact
consid
conjunct
biomark
data
determin
sever
ill
although
studi
aim
toward
explain
underli
associ
singl
variabl
alon
may
suffici
enough
explain
drive
chang
nwldh
nwcaspas
nwldhnwcaspas
ratio
previous
mention
earlier
studi
demonstr
invers
relationship
nwldh
bronchiol
diseas
sever
children
top
quartil
significantli
lower
risk
hospit
studi
univari
analysi
appear
contradict
previou
report
howev
report
includ
group
children
older
healthier
baselin
present
vari
degre
ill
greater
proport
requir
high
level
care
also
sampl
process
one
cycl
sampl
use
earlier
studi
underw
multipl
cycl
may
advers
affect
stabil
ldh
isoenzym
qualiti
sampl
current
studi
ensur
qualiti
sampl
provid
feedback
real
time
detect
siga
nasal
wash
fluid
use
nasal
wash
sampl
thaw
determin
ldh
caspas
activ
also
previou
report
data
nwldhnwcaspas
ratio
perform
believ
help
explain
domin
cellular
pathway
necrosi
versu
apoptosi
ldh
deriv
respiratori
tract
fluid
previous
state
multipl
linear
model
show
invers
relationship
nwldh
nwldhnwcaspas
ratio
sever
bronchiol
children
admit
acu
compar
sent
home
take
account
age
patient
overal
observ
time
support
concept
biomark
nwldh
nwcaspas
reflect
complex
pathway
control
respiratori
viral
infect
bronchiol
diseas
sever
work
explor
balanc
necrosi
apoptosi
done
invitro
studi
show
viral
infect
human
lung
epitheli
cell
releas
ldh
addit
studi
would
like
includ
clinic
work
hospit
infant
time
demonstr
overal
trajectori
biomark
rel
clinic
statu
limit
studi
perform
one
site
one
respiratori
viru
season
thu
find
may
applic
region
differ
demograph
viral
epidemiolog
addit
subject
recruit
part
two
origin
separ
studi
subject
recruit
icu
sampl
within
first
hour
admiss
patient
enrol
sampl
time
present
er
may
impact
nwldh
activ
higher
concentr
detect
later
acut
phase
ill
part
support
significantli
higher
proport
children
admit
acu
day
ill
compar
children
discharg
home
emerg
depart
conclus
nwldh
nwcaspas
nwldhnwcaspas
ratio
use
combin
help
predict
outcom
children
bronchiol
understand
underli
relationship
ldh
caspas
innat
immun
respons
respiratori
viral
pathogen
like
strengthen
predict
abil
demograph
variabl
interact
effect
must
also
consid
explain
biomark
interest
respect
outcom
disposit
ratio
nwldhnwcaspas
reflect
innat
immun
balanc
necrosi
apoptosi
control
diseas
sever
children
present
bronchiol
observ
support
hypothesi
earli
immun
respons
control
acut
viral
respiratori
tract
infect
excess
necrosi
epitheli
cell
either
direct
viral
replic
secondari
inflammatori
respons
detriment
host
versu
regul
apoptot
antivir
proinflammatori
pathway
epitheli
cell
design
inhibit
viral
replic
progress
airway
injuri
biomark
like
nwldh
nwcaspas
help
elucid
pathogenesi
viral
induc
airway
diseas
like
serv
good
predict
biomark
clinic
set
studi
ldh
caspas
biomark
may
reveal
novel
target
diagnost
tool
would
aid
clinician
manag
disposit
children
bronchiol
